CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced the appointment of Ms. Tamar Thompson to the Company’s Board of Directors (“Board”),…Read More
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
